课题基金 / 基金详情

Regulation of Collagen Formation in Pulmonary Fibrosis

Regulation of Collagen Formation in Pulmonary Fibrosis
肺纤维化中胶原蛋白形成的调节
批准号:
6466292
负责人:
Ronald Howard Goldstein
金额:
$36.34万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2006-07-31

项目摘要

项目成果

Ronald Howard Goldstein的其他基金

相似基金

相关文献

中文摘要
翻译
肌成纤维细胞的活化是肺间质纤维化的中心特征。 本提案的目的是研究肺肌成纤维细胞表型的调节,重点是这些细胞增加基质沉积所利用的信号转导途径。 在体内肺损伤后,间质壁中的成纤维细胞表现出肌成纤维细胞表型,α-平滑肌肌动蛋白和α 1(I)胶原mRNA表达增加。 我们已经表明,前列腺素E2(PGE 2)下调α 1(I)胶原蛋白,结缔组织生长因子和α-平滑肌肌动蛋白mRNA的稳态水平。 PGE 2还刺激Ca ~(2+)激活的K ~+通道,使细胞体积减小,并使细胞对死亡受体介导的凋亡敏感。 这些结果表明,PGE 2抑制肌成纤维细胞表型的表达,并具有显着的抗纤维化特性。 初步数据表明,用PGE 2处理成纤维细胞引起磷脂酰肌醇3-激酶(PI-3 K)的降低,如通过磷酸化蛋白激酶B/Akt的水平所评估的。 采用PI-3 K和突变体Akt结构的抑制剂,我们发现PI-3 K系统的活性调节α 1(I)胶原mRNA的稳定性。 我们假设成纤维细胞活化和肌成纤维细胞表型的发展涉及PI-3 K信号转导途径活性的上调,其反过来上调α 1(I)胶原和α-平滑肌肌动蛋白mRNA表达。 PGE 2通过影响PI-3 K活性和降低细胞水合作用来下调这些过程。 我们计划使用细胞和分子的方法来测试我们的假设在体外和体内。 我们的研究将为肌成纤维细胞的调控提供新的见解,并为肺纤维化的治疗提供新的治疗选择。
英文摘要
The activation of myofibroblast is a central feature of interstitial pulmonary fibrosis. The objective of this proposal is to examine the regulation of the lung myofibroblast phenotype with an emphasis on the signal transduction pathways utilized by these cells to increase matrix deposition. Following lung injury in vivo, fibroblasts in the interstitial wall display a myofibroblast phenotype with increased expression of alpha-smooth muscle actin and alpha1(I) collagen mRNA. We have shown that prostaglandin E2 (PGE2) down-regulated steady state levels for alpha1(I) collagen, connective tissue growth factor and alpha- smooth muscle actin mRNA. PGE2 also stimulated Ca2+ activated K+ channels that decrease cell volume, and sensitized the cells to death receptor mediated apoptosis. These results indicate that PGE2 inhibits expression of the myofibroblast phenotype and has significant anti-fibrogenic properties. Preliminary data indicate that treatment of fibroblasts with PGE2 causes decreases in phosphatidylinositiol 3-kinase (PI-3K) as assessed by levels of phosphorylated protein kinase B/Akt. Employing inhibitors to PI-3K and mutant Akt constructs, we find that the activity of the PI-3K system regulates the stability of the alpha1(I) collagen mRNA. We hypothesize that fibroblast activation and the development of the myofibroblast phenotype involves an up- regulation in the activity of the PI-3K signal transduction pathways which in turn up-regulates alpha1(I) collagen and alpha- smooth muscle actin mRNA expression. PGE2 down-regulates these processes by affecting PI-3K activity and decreasing cell hydration. We plan to use cellular and molecular approaches to test our hypothesis in vitro and in vivo. Our studies will provide new insights into the regulation of the myofibroblast and suggest new therapeutic options for the treatment of pulmonary fibrosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
  • 批准号:
    8543292
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Ronald Howard Goldstein
  • 依托单位:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
  • 批准号:
    8682796
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Ronald Howard Goldstein
  • 依托单位:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
  • 批准号:
    9794752
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Ronald Howard Goldstein
  • 依托单位:
Tadalafil for Pulmonary Hypertension Associated with Chronic Lung Disease
  • 批准号:
    8794424
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Ronald Howard Goldstein
  • 依托单位:
海外基金